Global Intravitreal Injections Market Research Report 2026(Status and Outlook)

May 2026 | 139 pages | ID: GC39FD212684EN
Bosson Research

Abstracts

Intravitreal injections refer to pharmaceutical agents administered directly into the vitreous cavity of the eye, enabling high intraocular bioavailability for treating retinal diseases such as neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and myopic CNV. These agents include anti-VEGF biologics, corticosteroid implants, sustained-release injectables, and emerging gene-therapy vectors. As retinal diseases continue rising globally due to aging populations, diabetes prevalence, and increased myopia, intravitreal injections remain the gold-standard treatment modality in ophthalmology.The upstream segment consists of biologics manufacturing platforms, recombinant protein expression systems, viral vector producers, and excipient suppliers specializing in sterile injectables. High-purity raw materials, aseptic fill-finish capabilities, and cold-chain logistics are essential due to the biological and temperature-sensitive nature of these drugs. Midstream players are the pharmaceutical companies responsible for drug formulation, clinical development, regulatory approval, large-scale GMP production, and packaging in prefilled syringes or sterile vials.Downstream, ophthalmologists, retina specialists, hospitals, and ambulatory surgical centers deliver the injections to patients, while distributors and specialty pharmacies manage storage, reimbursement, and last-mile delivery. Health-insurance systems—including Medicare/Medicaid in the U.S. and national health insurers in Europe—play a central role in determining pricing, uptake, and treatment frequency, making reimbursement a crucial commercial success factor.Gross margins in the intravitreal injection market are among the highest in specialty pharmaceuticals, typically ranging from 65% to 85% for leading biologics such as anti-VEGF agents. High barriers to entry, strong patent protection, complex manufacturing, and the clinical necessity of repeated dosing support elevated profitability. Steroid implants and sustained-release technologies exhibit slightly lower but still attractive margins due to device-drug combination complexity.

The global Intravitreal Injections market size was estimated at USD 17965.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Intravitreal Injections market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Intravitreal Injections market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Intravitreal Injections market.

Global Intravitreal Injections Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Regeneron Pharmaceuticals
• Bausch & Lomb
• Novartis
• AbbVie (Allergan)
• Alimera Sciences
• Roche
• Bristol-Myers Squibb
• Bayer
• Bausch + Lomb
• EyePoint Pharmaceuticals

Market Segmentation (by Type)

• Anti-VEGF Agents
• Corticosteroids / Steroid Implants
• Thrombolytic / Enzymatic Agents
• Others

Market Segmentation (by Application)

• Macular Degeneration
• Macular Edema
• Uveitis
• Retinal Vein Occlusion
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Intravitreal Injections Market

Overview of the regional outlook of the Intravitreal Injections Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravitreal Injections Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Intravitreal Injections, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Intravitreal Injections
1.2 Key Market Segments
  1.2.1 Intravitreal Injections Segment by Type
  1.2.2 Intravitreal Injections Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INTRAVITREAL INJECTIONS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Intravitreal Injections Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Intravitreal Injections Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INTRAVITREAL INJECTIONS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Intravitreal Injections Product Life Cycle
3.3 Global Intravitreal Injections Sales by Manufacturers (2020-2025)
3.4 Global Intravitreal Injections Revenue Market Share by Manufacturers (2020-2025)
3.5 Intravitreal Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Intravitreal Injections Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Intravitreal Injections Market Competitive Situation and Trends
  3.8.1 Intravitreal Injections Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Intravitreal Injections Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 INTRAVITREAL INJECTIONS INDUSTRY CHAIN ANALYSIS

4.1 Intravitreal Injections Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INTRAVITREAL INJECTIONS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Intravitreal Injections Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Intravitreal Injections Market
5.7 ESG Ratings of Leading Companies

6 INTRAVITREAL INJECTIONS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intravitreal Injections Sales Market Share by Type (2020-2025)
6.3 Global Intravitreal Injections Market Size by Type (2020-2025)
6.4 Global Intravitreal Injections Price by Type (2020-2025)

7 INTRAVITREAL INJECTIONS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intravitreal Injections Market Sales by Application (2020-2025)
7.3 Global Intravitreal Injections Market Size (M USD) by Application (2020-2025)
7.4 Global Intravitreal Injections Sales Growth Rate by Application (2020-2025)

8 INTRAVITREAL INJECTIONS MARKET SALES BY REGION

8.1 Global Intravitreal Injections Sales by Region
  8.1.1 Global Intravitreal Injections Sales by Region
  8.1.2 Global Intravitreal Injections Sales Market Share by Region
8.2 Global Intravitreal Injections Market Size by Region
  8.2.1 Global Intravitreal Injections Market Size by Region
  8.2.2 Global Intravitreal Injections Market Size by Region
8.3 North America
  8.3.1 North America Intravitreal Injections Sales by Country
  8.3.2 North America Intravitreal Injections Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Intravitreal Injections Sales by Country
  8.4.2 Europe Intravitreal Injections Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Intravitreal Injections Sales by Region
  8.5.2 Asia Pacific Intravitreal Injections Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Intravitreal Injections Sales by Country
  8.6.2 South America Intravitreal Injections Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Intravitreal Injections Sales by Region
  8.7.2 Middle East and Africa Intravitreal Injections Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 INTRAVITREAL INJECTIONS MARKET PRODUCTION BY REGION

9.1 Global Production of Intravitreal Injections by Region(2020-2025)
9.2 Global Intravitreal Injections Revenue Market Share by Region (2020-2025)
9.3 Global Intravitreal Injections Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Intravitreal Injections Production
  9.4.1 North America Intravitreal Injections Production Growth Rate (2020-2025)
  9.4.2 North America Intravitreal Injections Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Intravitreal Injections Production
  9.5.1 Europe Intravitreal Injections Production Growth Rate (2020-2025)
  9.5.2 Europe Intravitreal Injections Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Intravitreal Injections Production (2020-2025)
  9.6.1 Japan Intravitreal Injections Production Growth Rate (2020-2025)
  9.6.2 Japan Intravitreal Injections Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Intravitreal Injections Production (2020-2025)
  9.7.1 China Intravitreal Injections Production Growth Rate (2020-2025)
  9.7.2 China Intravitreal Injections Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Regeneron Pharmaceuticals
  10.1.1 Regeneron Pharmaceuticals Basic Information
  10.1.2 Regeneron Pharmaceuticals Intravitreal Injections Product Overview
  10.1.3 Regeneron Pharmaceuticals Intravitreal Injections Product Market Performance
  10.1.4 Regeneron Pharmaceuticals Business Overview
  10.1.5 Regeneron Pharmaceuticals SWOT Analysis
  10.1.6 Regeneron Pharmaceuticals Recent Developments
10.2 Bausch and Lomb
  10.2.1 Bausch and Lomb Basic Information
  10.2.2 Bausch and Lomb Intravitreal Injections Product Overview
  10.2.3 Bausch and Lomb Intravitreal Injections Product Market Performance
  10.2.4 Bausch and Lomb Business Overview
  10.2.5 Bausch and Lomb SWOT Analysis
  10.2.6 Bausch and Lomb Recent Developments
10.3 Novartis
  10.3.1 Novartis Basic Information
  10.3.2 Novartis Intravitreal Injections Product Overview
  10.3.3 Novartis Intravitreal Injections Product Market Performance
  10.3.4 Novartis Business Overview
  10.3.5 Novartis SWOT Analysis
  10.3.6 Novartis Recent Developments
10.4 AbbVie (Allergan)
  10.4.1 AbbVie (Allergan) Basic Information
  10.4.2 AbbVie (Allergan) Intravitreal Injections Product Overview
  10.4.3 AbbVie (Allergan) Intravitreal Injections Product Market Performance
  10.4.4 AbbVie (Allergan) Business Overview
  10.4.5 AbbVie (Allergan) Recent Developments
10.5 Alimera Sciences
  10.5.1 Alimera Sciences Basic Information
  10.5.2 Alimera Sciences Intravitreal Injections Product Overview
  10.5.3 Alimera Sciences Intravitreal Injections Product Market Performance
  10.5.4 Alimera Sciences Business Overview
  10.5.5 Alimera Sciences Recent Developments
10.6 Roche
  10.6.1 Roche Basic Information
  10.6.2 Roche Intravitreal Injections Product Overview
  10.6.3 Roche Intravitreal Injections Product Market Performance
  10.6.4 Roche Business Overview
  10.6.5 Roche Recent Developments
10.7 Bristol-Myers Squibb
  10.7.1 Bristol-Myers Squibb Basic Information
  10.7.2 Bristol-Myers Squibb Intravitreal Injections Product Overview
  10.7.3 Bristol-Myers Squibb Intravitreal Injections Product Market Performance
  10.7.4 Bristol-Myers Squibb Business Overview
  10.7.5 Bristol-Myers Squibb Recent Developments
10.8 Bayer
  10.8.1 Bayer Basic Information
  10.8.2 Bayer Intravitreal Injections Product Overview
  10.8.3 Bayer Intravitreal Injections Product Market Performance
  10.8.4 Bayer Business Overview
  10.8.5 Bayer Recent Developments
10.9 Bausch + Lomb
  10.9.1 Bausch + Lomb Basic Information
  10.9.2 Bausch + Lomb Intravitreal Injections Product Overview
  10.9.3 Bausch + Lomb Intravitreal Injections Product Market Performance
  10.9.4 Bausch + Lomb Business Overview
  10.9.5 Bausch + Lomb Recent Developments
10.10 EyePoint Pharmaceuticals
  10.10.1 EyePoint Pharmaceuticals Basic Information
  10.10.2 EyePoint Pharmaceuticals Intravitreal Injections Product Overview
  10.10.3 EyePoint Pharmaceuticals Intravitreal Injections Product Market Performance
  10.10.4 EyePoint Pharmaceuticals Business Overview
  10.10.5 EyePoint Pharmaceuticals Recent Developments

11 INTRAVITREAL INJECTIONS MARKET FORECAST BY REGION

11.1 Global Intravitreal Injections Market Size Forecast
11.2 Global Intravitreal Injections Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Intravitreal Injections Market Size Forecast by Country
  11.2.3 Asia Pacific Intravitreal Injections Market Size Forecast by Region
  11.2.4 South America Intravitreal Injections Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Intravitreal Injections by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Intravitreal Injections Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Intravitreal Injections by Type (2026-2035)
  12.1.2 Global Intravitreal Injections Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Intravitreal Injections by Type (2026-2035)
12.2 Global Intravitreal Injections Market Forecast by Application (2026-2035)
  12.2.1 Global Intravitreal Injections Sales (K MT) Forecast by Application
  12.2.2 Global Intravitreal Injections Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Intravitreal Injections Market Size by Type (M USD)
Table 4. Global Intravitreal Injections Market Size by Application
Table 5. Intravitreal Injections Market Size Comparison by Region (M USD)
Table 6. Global Intravitreal Injections Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Intravitreal Injections Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Intravitreal Injections Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Intravitreal Injections Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injections as of 2025)
Table 11. Global Market Intravitreal Injections Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Intravitreal Injections Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intravitreal Injections Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Intravitreal Injections Sales by Type (K MT)
Table 27. Global Intravitreal Injections Market Size by Type (M USD)
Table 28. Global Intravitreal Injections Sales (K MT) by Type (2020-2025)
Table 29. Global Intravitreal Injections Sales Market Share by Type (2020-2025)
Table 30. Global Intravitreal Injections Market Size (M USD) by Type (2020-2025)
Table 31. Global Intravitreal Injections Market Share by Type (2020-2025)
Table 32. Global Intravitreal Injections Price (USD/KG) by Type (2020-2025)
Table 33. Global Intravitreal Injections Sales (K MT) by Application
Table 34. Global Intravitreal Injections Market Size by Application
Table 35. Global Intravitreal Injections Sales by Application (2020-2025) & (K MT)
Table 36. Global Intravitreal Injections Sales Market Share by Application (2020-2025)
Table 37. Global Intravitreal Injections Market Size by Application (2020-2025) & (M USD)
Table 38. Global Intravitreal Injections Market Share by Application (2020-2025)
Table 39. Global Intravitreal Injections Sales Growth Rate by Application (2020-2025)
Table 40. Global Intravitreal Injections Sales by Region (2020-2025) & (K MT)
Table 41. Global Intravitreal Injections Sales Market Share by Region (2020-2025)
Table 42. Global Intravitreal Injections Market Size by Region (2020-2025) & (M USD)
Table 43. Global Intravitreal Injections Market Size by Region (2020-2025)
Table 44. North America Intravitreal Injections Sales by Country (2020-2025) & (K MT)
Table 45. North America Intravitreal Injections Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Intravitreal Injections Sales by Country (2020-2025) & (K MT)
Table 47. Europe Intravitreal Injections Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Intravitreal Injections Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Intravitreal Injections Market Size by Region (2020-2025) & (M USD)
Table 50. South America Intravitreal Injections Sales by Country (2020-2025) & (K MT)
Table 51. South America Intravitreal Injections Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Intravitreal Injections Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Intravitreal Injections Market Size by Region (2020-2025) & (M USD)
Table 54. Global Intravitreal Injections Production (K MT) by Region(2020-2025)
Table 55. Global Intravitreal Injections Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Intravitreal Injections Revenue Market Share by Region (2020-2025)
Table 57. Global Intravitreal Injections Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Intravitreal Injections Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Intravitreal Injections Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Intravitreal Injections Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Intravitreal Injections Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Regeneron Pharmaceuticals Basic Information
Table 63. Regeneron Pharmaceuticals Intravitreal Injections Product Overview
Table 64. Regeneron Pharmaceuticals Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Regeneron Pharmaceuticals Business Overview
Table 66. Regeneron Pharmaceuticals SWOT Analysis
Table 67. Regeneron Pharmaceuticals Recent Developments
Table 68. Bausch and Lomb Basic Information
Table 69. Bausch and Lomb Intravitreal Injections Product Overview
Table 70. Bausch and Lomb Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bausch and Lomb Business Overview
Table 72. Bausch and Lomb SWOT Analysis
Table 73. Bausch and Lomb Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Intravitreal Injections Product Overview
Table 76. Novartis Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. AbbVie (Allergan) Basic Information
Table 81. AbbVie (Allergan) Intravitreal Injections Product Overview
Table 82. AbbVie (Allergan) Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AbbVie (Allergan) Business Overview
Table 84. AbbVie (Allergan) Recent Developments
Table 85. Alimera Sciences Basic Information
Table 86. Alimera Sciences Intravitreal Injections Product Overview
Table 87. Alimera Sciences Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Alimera Sciences Business Overview
Table 89. Alimera Sciences Recent Developments
Table 90. Roche Basic Information
Table 91. Roche Intravitreal Injections Product Overview
Table 92. Roche Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Roche Business Overview
Table 94. Roche Recent Developments
Table 95. Bristol-Myers Squibb Basic Information
Table 96. Bristol-Myers Squibb Intravitreal Injections Product Overview
Table 97. Bristol-Myers Squibb Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Recent Developments
Table 100. Bayer Basic Information
Table 101. Bayer Intravitreal Injections Product Overview
Table 102. Bayer Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bayer Business Overview
Table 104. Bayer Recent Developments
Table 105. Bausch + Lomb Basic Information
Table 106. Bausch + Lomb Intravitreal Injections Product Overview
Table 107. Bausch + Lomb Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bausch + Lomb Business Overview
Table 109. Bausch + Lomb Recent Developments
Table 110. EyePoint Pharmaceuticals Basic Information
Table 111. EyePoint Pharmaceuticals Intravitreal Injections Product Overview
Table 112. EyePoint Pharmaceuticals Intravitreal Injections Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. EyePoint Pharmaceuticals Business Overview
Table 114. EyePoint Pharmaceuticals Recent Developments
Table 115. Global Intravitreal Injections Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Intravitreal Injections Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Intravitreal Injections Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Intravitreal Injections Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Intravitreal Injections Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Intravitreal Injections Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Intravitreal Injections Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Intravitreal Injections Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Intravitreal Injections Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Intravitreal Injections Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Intravitreal Injections Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Intravitreal Injections Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Intravitreal Injections Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Intravitreal Injections Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Intravitreal Injections Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Intravitreal Injections Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Intravitreal Injections Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Intravitreal Injections
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intravitreal Injections Market Size (M USD), 2025-2035
Figure 5. Global Intravitreal Injections Market Size (M USD) (2020-2035)
Figure 6. Global Intravitreal Injections Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intravitreal Injections Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Intravitreal Injections Product Life Cycle
Figure 13. Intravitreal Injections Sales Share by Manufacturers in 2025
Figure 14. Global Intravitreal Injections Revenue Share by Manufacturers in 2025
Figure 15. Intravitreal Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Intravitreal Injections Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Intravitreal Injections Revenue in 2025
Figure 18. Industry Chain Map of Intravitreal Injections
Figure 19. Global Intravitreal Injections Market PEST Analysis
Figure 20. Global Intravitreal Injections Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Intravitreal Injections Market Share by Type
Figure 27. Sales Market Share of Intravitreal Injections by Type (2020-2025)
Figure 28. Sales Market Share of Intravitreal Injections by Type in 2025
Figure 29. Market Share of Intravitreal Injections by Type (2020-2025)
Figure 30. Market Share of Intravitreal Injections by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Intravitreal Injections Market Share by Application
Figure 33. Global Intravitreal Injections Sales Market Share by Application (2020-2025)
Figure 34. Global Intravitreal Injections Sales Market Share by Application in 2025
Figure 35. Global Intravitreal Injections Market Share by Application (2020-2025)
Figure 36. Global Intravitreal Injections Market Share by Application in 2025
Figure 37. Global Intravitreal Injections Sales Growth Rate by Application (2020-2025)
Figure 38. Global Intravitreal Injections Sales Market Share by Region (2020-2025)
Figure 39. Global Intravitreal Injections Market Size by Region (2020-2025)
Figure 40. North America Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Intravitreal Injections Sales Market Share by Country in 2024
Figure 43. North America Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Intravitreal Injections Market Size by Country in 2024
Figure 45. U.S. Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Intravitreal Injections Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Intravitreal Injections Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Intravitreal Injections Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Intravitreal Injections Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Intravitreal Injections Sales Market Share by Country in 2024
Figure 53. Europe Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Intravitreal Injections Market Size by Country in 2024
Figure 55. Germany Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Intravitreal Injections Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Intravitreal Injections Sales Market Share by Region in 2024
Figure 67. Asia Pacific Intravitreal Injections Market Size by Region in 2024
Figure 68. China Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Intravitreal Injections Sales and Growth Rate (K MT)
Figure 79. South America Intravitreal Injections Sales Market Share by Country in 2024
Figure 80. South America Intravitreal Injections Market Size and Growth Rate (M USD)
Figure 81. South America Intravitreal Injections Market Size by Country in 2024
Figure 82. Brazil Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Intravitreal Injections Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Intravitreal Injections Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Intravitreal Injections Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Intravitreal Injections Market Size by Region in 2024
Figure 92. Saudi Arabia Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Intravitreal Injections Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Intravitreal Injections Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Intravitreal Injections Production Market Share by Region (2020-2025)
Figure 103. North America Intravitreal Injections Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Intravitreal Injections Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Intravitreal Injections Production (K MT) Growth Rate (2020-2025)
Figure 106. China Intravitreal Injections Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Intravitreal Injections Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Intravitreal Injections Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Intravitreal Injections Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Intravitreal Injections Market Share Forecast by Type (2026-2035)
Figure 111. Global Intravitreal Injections Sales Forecast by Application (2026-2035)
Figure 112. Global Intravitreal Injections Market Share Forecast by Application (2026-2035)